Evidence method
Level · gp.fundamentals.debt_to_revenue
298.81% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
MEDS · Jun 30, 2025
DataMeds AI, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001641172-25-024873General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-26.69% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
115.92% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
6.49% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-70.60% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
12.00% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History7 statesHistory building
Period transition
What moved in the state?
- Previous
- 222.06%
- Current
- 298.81%
- Delta
- 76.75%
- Previous
- -12.40%
- Current
- -26.69%
- Delta
- -14.28%
- Previous
- 89.59%
- Current
- 115.92%
- Delta
- 26.32%
- Previous
- 6.38%
- Current
- 6.49%
- Delta
- 0.12%
- Previous
- -288.57%
- Current
- -70.60%
- Delta
- 217.97%
- Previous
- 255.66%
- Current
- 12.00%
- Delta
- -243.66%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · MEDS Fundamental State →Transitioned To · MEDS Fundamental State →Transitioned To · MEDS BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · MEDS CASH_GENERATION_DECREASED →Transitioned To · MEDS INVENTORY_PRESSURE_INCREASED →Transitioned To · MEDS MARGIN_INCREASED →Transitioned To · MEDS PROFITABILITY_INCREASED →Transitioned To · MEDS SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.